Virtual or in person, we participate in many conferences as speakers, exhibitors or as attendees. Let us know if you’d like to connect at any of the forthcoming meeting we’re attending.
During agrochemical or drug discovery processes, it is crucial to unambiguously elucidate the structure of the metabolites and process impurities for further assessment. This symposium highlights innovative approaches and newest development in unknown identification and structure elucidation technologies.
EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. EFMC-ISMC 2021 will also feature most recent advances in new technologies such as, artificial intelligence in drug discovery and chemical synthesis, the role carbohydrates in disease pathology and carbohydrate-based drug discovery, the exploitation of RNA as drug target, small molecule-induced stem cell differentiation, or the impact of cryo-EM on drug discovery and design.
This virtual meeting will bring together individuals who are actively working on drug/xenobiotic research in diverse fields including basic and clinical pharmacology and therapeutics, toxicology, oncology, endocrinology, physiology, biochemistry, medicinal chemistry, molecular and structural biology, and genetics.
Reflecting current trends in medicinal chemistry and pharmaceutical research, the scientific programme will feature lectures on the full range of drug targets, key enabling processes and technologies together with late breaker talks. Liam will be presenting a poster at this meeting on “Glucuronide Metabolites, Why Bother?”
The workshop is designed to provide detailed guidance on objectives, study designs, and data analysis of metabolism studies of small molecules, siRNAs, and protein therapeutics. Speakers of this workshop bring a wealth of knowledge from the pharmaceutical industry in drug metabolism sciences.
Julia will be giving a talk at this meeting on “One-Stop Metabolite Shop; Employing Multiple Tools for Accessing Drug Metabolites.” The event programme will incorporate sessions themed around the following key topics: DMPK and Drug Discovery. DMPK and Drug Safety. Analytical and Computational Advances in DMPK
Stay up to date with the latest news from Hypha Discovery
Sign up for our Newsletter to receive interesting updates and scientific case studies about Hypha’s metabolite generation capabilities and lead optimization solutions
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.